001037621 001__ 1037621
001037621 005__ 20250203124507.0
001037621 0247_ $$2doi$$a10.1093/neuonc/noae078
001037621 0247_ $$2ISSN$$a1522-8517
001037621 0247_ $$2ISSN$$a1523-5866
001037621 0247_ $$2pmid$$a38970818
001037621 0247_ $$2WOS$$aWOS:001263250000001
001037621 037__ $$aFZJ-2025-00792
001037621 082__ $$a610
001037621 1001_ $$0P:(DE-Juel1)143792$$aGalldiks, Norbert$$b0$$eCorresponding author$$ufzj
001037621 245__ $$aPET imaging of gliomas: Status quo and quo vadis?
001037621 260__ $$aOxford$$bOxford Univ. Press$$c2024
001037621 3367_ $$2DRIVER$$aarticle
001037621 3367_ $$2DataCite$$aOutput Types/Journal article
001037621 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1737442006_21956
001037621 3367_ $$2BibTeX$$aARTICLE
001037621 3367_ $$2ORCID$$aJOURNAL_ARTICLE
001037621 3367_ $$00$$2EndNote$$aJournal Article
001037621 520__ $$aPET imaging, particularly using amino acid tracers, has become a valuable adjunct to anatomical MRI in the clinical management of patients with glioma. Collaborative international efforts have led to the development of clinical and technical guidelines for PET imaging in gliomas. The increasing readiness of statutory health insurance agencies, especially in European countries, to reimburse amino acid PET underscores its growing importance in clinical practice. Integrating artificial intelligence and radiomics in PET imaging of patients with glioma may significantly improve tumor detection, segmentation, and response assessment. Efforts are ongoing to facilitate the clinical translation of these techniques. Considerable progress in computer technology developments (eg quantum computers) may be helpful to accelerate these efforts. Next-generation PET scanners, such as long-axial field-of-view PET/CT scanners, have improved image quality and body coverage and therefore expanded the spectrum of indications for PET imaging in Neuro-Oncology (eg PET imaging of the whole spine). Encouraging results of clinical trials in patients with glioma have prompted the development of PET tracers directing therapeutically relevant targets (eg the mutant isocitrate dehydrogenase) for novel anticancer agents in gliomas to improve response assessment. In addition, the success of theranostics for the treatment of extracranial neoplasms such as neuroendocrine tumors and prostate cancer has currently prompted efforts to translate this approach to patients with glioma. These advancements highlight the evolving role of PET imaging in Neuro-Oncology, offering insights into tumor biology and treatment response, thereby informing personalized patient care. Nevertheless, these innovations warrant further validation in the near future.
001037621 536__ $$0G:(DE-HGF)POF4-5252$$a5252 - Brain Dysfunction and Plasticity (POF4-525)$$cPOF4-525$$fPOF IV$$x0
001037621 588__ $$aDataset connected to CrossRef, Journals: juser.fz-juelich.de
001037621 7001_ $$0P:(DE-Juel1)145110$$aLohmann, Philipp$$b1
001037621 7001_ $$0P:(DE-Juel1)184842$$aFriedrich, Michel$$b2$$ufzj
001037621 7001_ $$0P:(DE-HGF)0$$aWerner, Jan-Michael$$b3
001037621 7001_ $$0P:(DE-HGF)0$$aStetter, Isabelle$$b4
001037621 7001_ $$0P:(DE-Juel1)190394$$aWollring, Michael M$$b5
001037621 7001_ $$0P:(DE-HGF)0$$aCeccon, Garry$$b6
001037621 7001_ $$0P:(DE-Juel1)156479$$aStegmayr, Carina$$b7$$ufzj
001037621 7001_ $$0P:(DE-Juel1)188107$$aKrause, Sandra$$b8$$ufzj
001037621 7001_ $$0P:(DE-Juel1)131720$$aFink, Gereon R$$b9$$ufzj
001037621 7001_ $$0P:(DE-HGF)0$$aLaw, Ian$$b10
001037621 7001_ $$0P:(DE-Juel1)131777$$aLangen, Karl-Josef$$b11$$ufzj
001037621 7001_ $$0P:(DE-HGF)0$$aTonn, Joerg-Christian$$b12
001037621 773__ $$0PERI:(DE-600)2094060-9$$a10.1093/neuonc/noae078$$gVol. 26, no. Supplement_9, p. S185 - S198$$nSupplement_9$$pS185 - S198$$tNeuro-Oncology$$v26$$x1522-8517$$y2024
001037621 8564_ $$uhttps://juser.fz-juelich.de/record/1037621/files/PDF.pdf$$yRestricted
001037621 909CO $$ooai:juser.fz-juelich.de:1037621$$pVDB
001037621 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)143792$$aForschungszentrum Jülich$$b0$$kFZJ
001037621 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)145110$$aForschungszentrum Jülich$$b1$$kFZJ
001037621 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)184842$$aForschungszentrum Jülich$$b2$$kFZJ
001037621 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)156479$$aForschungszentrum Jülich$$b7$$kFZJ
001037621 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)188107$$aForschungszentrum Jülich$$b8$$kFZJ
001037621 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131720$$aForschungszentrum Jülich$$b9$$kFZJ
001037621 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131777$$aForschungszentrum Jülich$$b11$$kFZJ
001037621 9131_ $$0G:(DE-HGF)POF4-525$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF4-5252$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vDecoding Brain Organization and Dysfunction$$x0
001037621 9141_ $$y2024
001037621 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2024-12-11$$wger
001037621 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bNEURO-ONCOLOGY : 2022$$d2024-12-11
001037621 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-11
001037621 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-11
001037621 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-11
001037621 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-11
001037621 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2024-12-11
001037621 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-11
001037621 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-11
001037621 915__ $$0StatID:(DE-HGF)9915$$2StatID$$aIF >= 15$$bNEURO-ONCOLOGY : 2022$$d2024-12-11
001037621 920__ $$lyes
001037621 9201_ $$0I:(DE-Juel1)INM-3-20090406$$kINM-3$$lKognitive Neurowissenschaften$$x0
001037621 980__ $$ajournal
001037621 980__ $$aVDB
001037621 980__ $$aI:(DE-Juel1)INM-3-20090406
001037621 980__ $$aUNRESTRICTED